CircAKT3 promotes the malignant development of GC by activating SLC1A5 expression via targeting miR-515-5p.
CircAKT3 promotes cell proliferation, survival and glutamine metabolism of gastric cancer by activating SLC1A5 expression via targeting miR-515-5p.